Literature DB >> 23415622

Low-density lipoprotein cholesterol versus particle number in middle school children.

Michele Mietus-Snyder1, Kimberly L Drews, James D Otvos, Steven M Willi, Gary D Foster, Russell Jago, John B Buse.   

Abstract

OBJECTIVES: To characterize lipids and lipoproteins in a diverse school-based cohort and identify features associated with discordance between low-density lipoprotein cholesterol (LDL-C) and LDL particle (LDL-P). STUDY
DESIGN: Sixth-grade children enrolled in the HEALTHY trial (n = 2384; mean age 11.3 ± 0.6 years; 54.2% female) were evaluated for standard lipids, lipoprotein particles measured by nuclear magnetic resonance, and homeostatic model of insulin resistance. Characteristics of subgroups with values of LDL-C and LDL-P discordant by >20 percentile units, an amount reasoned to be clinically significant, were compared.
RESULTS: Four-hundred twenty-eight (18%) of children were in the LDL-P < LDL-C subgroup and 375 (16%) in the LDL-P > LDL-C subgroup. Those with LDL-P > LDL-C had significantly greater body mass index, waist circumference, homeostatic model of insulin resistance, triglycerides, systolic and diastolic blood pressure, and reflected a greater Hispanic ethnic composition but fewer of black race than both the concordant (LDL-PLDL-C) and opposite discordant (LDL-P < LDL-C) subgroups.
CONCLUSIONS: There is as much lipoprotein cholesterol compositional heterogeneity in sixth graders as has been described in adults and a discordant atherogenic phenotype of LDL-P > LDL-C, common in obesity, is often missed when only LDL-C is considered. Conversely, many children with moderate-risk cholesterol measures (75th to 99th percentile) have a lower LDL-P burden.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Apolipoprotein B; BMI; Body mass index; CVD; Cardiovascular disease; HDL-C; HDL-P; HOMA-IR; High-density lipoprotein cholesterol; High-density lipoprotein particle; Homeostatic model of insulin resistance; LDL; LDL-C; LDL-P; Low-density lipoprotein; Low-density lipoprotein cholesterol; Low-density lipoprotein particle; NMR; Nuclear magnetic resonance; TC; TG; Total cholesterol; Triglycerides; VLDL; VLDL-P; Very-low-density lipoprotein; Very-low-density lipoprotein particle; apoB

Mesh:

Substances:

Year:  2013        PMID: 23415622      PMCID: PMC3659184          DOI: 10.1016/j.jpeds.2013.01.012

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

Review 1.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

Review 2.  Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.

Authors:  Ira Tabas; Kevin Jon Williams; Jan Borén
Journal:  Circulation       Date:  2007-10-16       Impact factor: 29.690

3.  Statin treatment in children with familial hypercholesterolemia: the younger, the better.

Authors:  Jessica Rodenburg; Maud N Vissers; Albert Wiegman; A S Paul van Trotsenburg; Anouk van der Graaf; Eric de Groot; Frits A Wijburg; John J P Kastelein; Barbara A Hutten
Journal:  Circulation       Date:  2007-07-30       Impact factor: 29.690

Review 4.  Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.

Authors:  John D Brunzell; Michael Davidson; Curt D Furberg; Ronald B Goldberg; Barbara V Howard; James H Stein; Joseph L Witztum
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

5.  Clinical implications of discordance between low-density lipoprotein cholesterol and particle number.

Authors:  James D Otvos; Samia Mora; Irina Shalaurova; Philip Greenland; Rachel H Mackey; David C Goff
Journal:  J Clin Lipidol       Date:  2011 Mar-Apr       Impact factor: 4.766

6.  Reversal of small, dense LDL subclass phenotype by normalization of adiposity.

Authors:  Patty W Siri-Tarino; Paul T Williams; Harriet S Fernstrom; Robin S Rawlings; Ronald M Krauss
Journal:  Obesity (Silver Spring)       Date:  2009-06-04       Impact factor: 5.002

7.  Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.

Authors:  Allan D Sniderman; Annie C St-Pierre; Bernard Cantin; Gilles R Dagenais; Jean-Pierre Després; Benoît Lamarche
Journal:  Am J Cardiol       Date:  2003-05-15       Impact factor: 2.778

Review 8.  Lipid screening and cardiovascular health in childhood.

Authors:  Stephen R Daniels; Frank R Greer
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

9.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766

10.  A self-report measure of pubertal status: Reliability, validity, and initial norms.

Authors:  A C Petersen; L Crockett; M Richards; A Boxer
Journal:  J Youth Adolesc       Date:  1988-04
View more
  8 in total

1.  Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents.

Authors:  Russell Jago; Kimberly L Drews; James D Otvos; Gary D Foster; Marsha D Marcus; John B Buse; Michele Mietus-Snyder; Steven M Willi
Journal:  J Pediatr       Date:  2014-02-05       Impact factor: 4.406

2.  Lipoprotein particle number and size predict vascular structure and function better than traditional lipids in adolescents and young adults.

Authors:  Elaine M Urbina; Connie E McCoy; Zhiqian Gao; Philip R Khoury; Amy S Shah; Lawrence M Dolan; Thomas R Kimball
Journal:  J Clin Lipidol       Date:  2017-06-03       Impact factor: 4.766

3.  Effectiveness and Safety of Statin Therapy in Children: A Real-World Clinical Practice Experience.

Authors:  Rae-Ellen W Kavey; Cedric Manlhiot; Kyle Runeckles; Tanveer Collins; Samuel S Gidding; Matthew Demczko; Sarah Clauss; Ashraf S Harahsheh; Michele Mietus-Syder; Michael Khoury; Nicolas Madsen; Brian W McCrindle
Journal:  CJC Open       Date:  2020-06-06

4.  Sex differences in the associations of visceral adiposity, homeostatic model assessment of insulin resistance, and body mass index with lipoprotein subclass analysis in obese adolescents.

Authors:  Jacquelyn A Hatch-Stein; Andrea Kelly; Samuel S Gidding; Babette S Zemel; Sheela N Magge
Journal:  J Clin Lipidol       Date:  2016-02-16       Impact factor: 4.766

5.  A double-blind randomized trial of fish oil to lower triglycerides and improve cardiometabolic risk in adolescents.

Authors:  Samuel S Gidding; Carol Prospero; Jobayer Hossain; Frances Zappalla; Prabhakaran Babu Balagopal; Bonita Falkner; Peter Kwiterovich
Journal:  J Pediatr       Date:  2014-07-07       Impact factor: 4.406

6.  Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study.

Authors:  R Jago; K L Drews; J D Otvos; S M Willi; J B Buse
Journal:  Int J Obes (Lond)       Date:  2016-05-04       Impact factor: 5.095

7.  Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study.

Authors:  Jacob Hartz; Ronald M Krauss; Mikael Göttsater; Olle Melander; Peter Nilsson; Michele Mietus-Snyder
Journal:  Int J Vasc Med       Date:  2020-04-28

8.  Postprandial dyslipidemia in insulin resistant states in adolescent populations.

Authors:  Victoria Higgins; Khosrow Adeli
Journal:  J Biomed Res       Date:  2020-01-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.